Three pharma stocks — Zydus Lifesciences, Jagsonpal Pharma, and Biocon Biologics — are set to be in focus today as key developments, from drug partnerships to leadership changes and USFDA inspections, drive investor attention. Read More | Source: The Hindu Business Line